LegoChem Biosciences signs deal with Prague's Sotio Biotech
LegoChem Biosciences has inked a technology transfer deal worth up to $1.03 billion with Sotio Biotech for antibody-drug conjugate (ADC) technology, the Kosdaq-listed company said Wednesday.